A topical skin cream could be used as a viable alternative to surgery for patients with a common type of skin cancer, a study led by researchers at The University of Nottingham found.The research, published in the Journal of Investigative Dermatology, found that imiquimod had high levels of success when used to treat basal cell carcinoma (BCC) over a period of five years.Hywel Williams, Professor of Dermato-Epidemiology and Co-Director of the Centre of Evidence-based Dermatology at the University, led the study along with Professor Fiona Bath-Hextall, Professor of Evidence-Based Healthcare in the University’s School of Health Sciences.
Click here for full story
The University of Nottingham
Applied Health Research Building
University Park, Nottingham
telephone: +44 (0) 115 84 68631
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs